Finding more information about your personal health or the health of your family has never been more meaningful than over the past year. For many individuals, patients and consumers, the need to address myriad questions and seek out additional areas of interest has become a quest. But in an age when information is ubiquitous and public health is top of mind, a new study on health fluency indicates that the road to such insight is now paved with multiple lanes and involves more than the traditional health care organizations and companies relied on before.
Microbial sciences company Seed Health closed a $40 million Series A financing round and Dutch company Anavo Therapeutics announced seed financing totaling €20 million ($24 million) to discover small molecules that target phosphatases.
Havas Health & You announced that HH&Y is the first health network to become a Global Content Partner as part of Veeva Systems’ Content Partner Program.
Amanda Powers-Han, Senior Partner and Chief Marketing Officer for Greater Than One, explores some real-life technology applications that are transforming healthcare today and tomorrow.
Greater Than One blasted into 2021 with the independent agency’s new “Better. Believe It.” branding and philosophy for the future model of healthcare marketing.
COVID-19 has accelerated opportunities for independent agencies even further while holding companies are struggling to make up for lost revenue across their portfolios in 2020.
The U.S. National Institutes of Health (NIH) awarded seven companies and academic institutions grants to develop digital health technology to help with the Covid-19 pandemic.
According to a new study by Worldwide Partners, the effect that Covid-19 is having on digital health adoption is set to be transformative. The survey that was conducted shows technology is playing a crucial and growing role in mitigating the healthcare crisis, especially via telehealth.
Faster Drug Development Processes Likely to Outlive COVID-19 Published: April 30, 2020 By Gail Dutton BioSpace The COVID-19 pandemic has increased the pace of drug development and regulatory approval dramatically, accelerating activities in ways that shorten the time needed to deliver safe, effective therapeutics, vaccines and diagnostics to patients. “It’s unfortunate it took a […]
As the J.P. Morgan Healthcare Conference entered the final day for 2020, a few topics rose to the top as trending, including the relative lack of big deals.